Skip to main content

Joana Carneiro da Silva, PhD

Academic Title:

Professor

Primary Appointment:

Microbiology and Immunology

Administrative Title:

Associate Director of Research at the Institute for Genome Sciences

Additional Title:

Professor, Institute for Genome Sciences; Affiliate Member, Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine; Honorary Member, Global Health and Tropical Medicine Research Center, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisbon, Portugal (GHTM / IHMT / NOVA).

Location:

Health Sciences Facility III, 670 West Baltimore St, Baltimore 21201

Phone (Primary):

(410) 706-0817

Phone (Secondary):

(410) 706-6755

Fax:

(410) 706-6756

Education and Training

1992                B.Sc., Biology, Universidade Clássica de Lisboa, Faculty of Sciences, Lisbon, Portugal

2000                Ph.D., Genetics, The University of Arizona, Tucson, AZ, USA (Advisor: Margaret G Kidwell)

2000-2002       Fogarty Postdoctoral Fellow, National Center for Biotechnology Information (NCBI), National Institutes of Health, Bethesda, MD, USA (Advisor: Alexey A Kondrashov)

2002-2005       Staff Scientist, The Institute for Genomic Research (TIGR), Rockville, MD, USA (Advisor: Jane M Carlton)

Biosketch

My group applies evolutionary genetics and genomic sciences to basic and translational research of parasitic infectious diseases. I have been studying infectious disease genomics since 2002. At The Institute for Genomic Research (TIGR) I was part of the team that launched the field of parasite genomics, with the publication of the genome of several Plasmodium and trypanosomatid species, Theileria parva and Trichomonas vaginalis. At the Institute for Genome Sciences, University of Maryland School of Medicine, we have ongoing projects on several parasites in the phylum Apicomplexa, with a focus on the causative agents of malaria in humans (genus  Plasmodium), theileriosis in cattle and horses (genus Theileria), human adn bovine babesiosis (genus  Babesia), and human cryptosporidiosis (genus  Cryptosporidium).

Ongoing projects include the (i) the study of species biology and the nature of host-parasite interactions, based on comparative genomics and (ii) studies of speciation, drug resistance, vaccine efficacy and vaccine design, informed by population genomics data. Our research is funded by NSF, NIH, USDA and the Bill and Melinda Gates Foundation.

 

Research/Clinical Keywords

Parasites: Plasmodium, Cryptosporidium, Babesia, Theileria; -omics: comparative genomics, transcriptomics, single cell transcriptomics Vaccinology: genomics of vaccine design and vaccine efficacy

Highlighted Publications

Mbambo G, Dwivedi A, Ifeonu OO, Munro JB, Shrestha B, Bromley RE, Hodges T, Adkins RS, Kouriba B, Diarra I, Niangaly A, Kone AK, Coulibaly D, Traore K, Dolo A, Thera MA, Laurens MB, Doumbo OK, Plowe CV, Berry AA, Travassos M, Lyke KE, Silva JC. Immunogenomic profile at baseline predicts host susceptibility to clinical malaria disease. Front Immunol. 2023 Jul 3;14:1179314. doi: 10.3389/fimmu.2023.1179314. eCollection 2023. PMID:37465667

Tavares W, Morais J, Martins JF, Scalsky RJ, Stabler TC, Medeiros MM, Fortes FJ, Arez AP, Silva JC. Malaria in Angola: recent progress, challenges and future opportunities using parasite demography studies. Malaria J 2022 Dec 28;21(1):396.doi: 10.1186/s12936-022-04424-y. PMID:36577996

Silva JC, A Dwivedi, KA Moser, M Sissoko, JE Epstein, S Healy, K Lyke, B Mordmüller, T Li, P Kremsner, P Duffy, TL Richie, BKL Sim, SL Hoffman. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. Nat Commun. 2022 Jun 13;13(1):3390. doi: 10.1038/s41467-022-30882-8. PMID: 35697668.

Moser KA, EF Drabek, A Dwivedi, J Crabtree, E Stucke, A Dara, Z Shah, M Adams, T Li, P Rodrigues, S Korsen, A Phillippy, A Ouattara, K Lyke, L Sadzewicz, L Tallon, MU Ferreira, M Laufer, M Travassos, S Takala-Harrison, CM Fraser, BKL Sim, SL Hoffman, CV Plowe, JC Silva. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential. Genome Med. 2020;12(1):6. Published 2020 Jan 8. doi:10.1186/s13073-019-0708-9. PMID:31915075.

Palmateer NC, K Tretina, J Orvis, J Crabtree, E Drabék, R Pelle, E Awino, HT Gotia, V Nene, L Tallon, CA Daubenberger, DP Knowles, RP Bishop, JC Silva. Capture-based enrichment method reveals extremely high genome-wide sequence diversity inTheileria parva, an intracellular pathogen of host lymphocytes. PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008781. doi: 10.1371/journal.pntd.0008781. PMID: 33119590.

Google Scholar profile

Additional Publication Citations

Awards and Affiliations

Links of Interest

×